Home >> Blog >> Qualitek Labs Limited IPO :Review, Valuation, Date & Today GMP
Qualitek Labs Limited IPO :Review, Valuation, Date & Today GMP
Table of Contents
Qualitek Labs Limited - Complete Overview
Established in 2018, Qualitek Labs Limited is actively involved in delivering testing, inspection, homologation, certification, and consultancy services across various industries, including automotive, defence, metals and metallurgy, environment and water, minerals, food and agriculture, pharma, and healthcare.
The company initiated its business operations by providing services from its testing laboratory established in Pune in 2018.
Subsequently, in 2022, Qualitek Labs expanded its operations by inaugurating a second laboratory in Bhubaneshwar.
Moreover, the company is currently in the process of establishing two additional testing laboratories in Pune and Noida.
With a workforce totalling 144 employees, Qualitek Labs achieved a revenue of Rs. 1913.66 lakhs in the fiscal year 2022-2023.
IPO Overview
The Qualitek Labs Limited IPO date is scheduled to open for subscription from January 18, 2024, to January 23, 2024. This BSE SME IPO has a lot size of 1200 shares.
The Qualitek Labs Limited IPO price is set at Rs 100 per share. The listing of this upcoming BSE SME IPO is anticipated on January 25, 2024.
The total issue size for this IPO is Rs. 19.64 Crores. The company has allocated 50% shares to retail investors and 50% to other investors.
Qualitek Labs Limited IPO Timetable (Tentative)
Events |
Date |
IPO Opening Date |
18 January 2024 |
IPO Closing Date |
23 January 2024 |
IPO Allotment Date |
24 January 2024 |
Refund initiation |
25 January 2024 |
IPO Listing Date |
29 January 2024 |
Qualitek Labs Limited IPO Details
IPO Opening & Closing Date |
18 January to 23 January 2024 |
Face value |
Rs.10 per share |
Issue Price |
Rs.100 per share |
Lot Size |
1200 Shares |
Price of 1 lot |
Rs.120,000 |
Issue Size |
1,964,400 Shares (aggregating up to Rs.19.64 Cr) |
Offer for sale |
NA |
Fresh issue |
1,964,400 Shares (aggregating up to Rs.19.64 Cr) |
Listing at |
BSE SME |
Issue Type |
Fixed Price Issue IPO |
Registrar |
Skyline Financial Services Pvt. Ltd. |
Qualitek Labs Limited IPO Lot Details
Minimum Lot Investment (Retail) |
1 Lot |
Maximum Lot Investment (Retail) |
1 Lot |
Minimum Lot Investment (HNI) |
2 Lot |
Qualitek Labs Limited IPO Reservation
Other Investor Share Portion |
50% |
Retail Investor Share Portion |
50% |
Company Financial
(Amount in Lakhs)
Period |
30 Sep 2023 |
31 Mar 2023 |
31 Mar 2022 |
Total Assets |
4,409.68 |
3,955.61 |
2,219.86 |
Total Revenue |
1,250.74 |
1,935.13 |
1,201.73 |
PAT |
200.93 |
296.91 |
113.57 |
Net worth |
1,187.46 |
986.52 |
189.61 |
Reserve & Surplus |
646.71 |
445.77 |
143.61 |
Total Borrowings |
2,499.59 |
2,344.67 |
1,728.68 |
Financial Statements of the Company
(Amount in Lakhs)
Particulars |
September 30, 2023 |
March 31, 2023 |
March 31, 2022 |
Lab-Wise |
|||
Bhubaneshwar |
189.71 |
260.21 |
73.07 |
Pune |
1059.21 |
1653.47 |
1123.50 |
Total |
1248.92 |
1913.68 |
1196.57 |
Segment-Wise |
|||
Bhubaneshwar |
|||
Environment & Water |
82.58 |
143.26 |
20.00 |
Food & Agricultural |
18.08 |
31.40 |
12.96 |
Minerals |
76.00 |
66.10 |
31.07 |
Pharma & Healthcare |
13.05 |
19.45 |
9.04 |
Total |
189.71 |
260.21 |
73.07 |
Pune |
|||
Automotive |
1009.91 |
1412.15 |
1020.02 |
Defence Product Testing |
45.50 |
224.15 |
63.53 |
Metal & Metallurgy testing |
3.80 |
17.17 |
39.95 |
Total |
1059.21 |
1653.47 |
1123.50 |
Grand Total |
1248.92 |
1913.68 |
1196.57 |
The Objective of the Issue
The company intend to utilize the net proceeds of the Issue to fulfil the following objectives
-
Funding capital expenditure towards the installation of plant and machinery for new & existing laboratories and for expansion of laboratories.
-
Repayment of unsecured loans to Promoter.
-
Funding of working capital requirements.
-
General corporate purposes.
Promoters and Management of Qualitek Labs Limited
The promoters of the company included Alok Kumar Agarwal, Antaryami Nayak, Kamal Grover, and TIC Services Private Limited.
Pre-issue Promoter shareholding |
99.99% |
Post-issue Promoter shareholding |
73.35% |
Qualitek Labs Limited IPO Lead Managers
-
Oneview Corporate Advisory Private Ltd
Peer Comparison
Following are the listed peers of the Qualitek Labs Limited
Name of Company |
EPS |
P/E |
Total Income(Rs. In Lakhs) |
Qualitek Labs Limited |
7.45 |
13.43 |
1935.13 |
Choksi Laboratories Ltd. |
4.69 |
11.74 |
3,465.76 |
IPO's Valuations
The Qualitek Labs Limited IPO price is set at Rs.100 per share.
Evaluation of P/E Ratio:
-
Considering the EPS of Rs 7.45, the resulting P/E ratio is 13.43.
Dividend Policy
The Company has not declared any dividend on the Equity Shares in the past three financial years. The future dividend payments depend upon the company's earnings and financial performance.
IPO's Strengths
-
Experienced Leadership and Management Team: The company is guided by a qualified and seasoned management team, possessing the expertise and vision necessary to effectively lead and expand the business while promoting sustainability goals.
-
Well-Established Brand: Qualitek Labs, an NABL ISO/IEC 17025:2017 accredited laboratory company, is founded by industry professionals with over a decade of experience in their respective fields, solidifying its position as a trusted brand.
-
Robust Technical Capability and IT Infrastructure: The infrastructure facilities in Pune and Bhubaneswar provide cutting-edge solutions to industries such as automotive, electrical, aerospace, and others. These solutions encompass testing, homologation, certification, and consultancy, showcasing strong technical capabilities supported by a robust IT infrastructure.
-
Customer-Centric Approach: Operating with a well-defined quality assurance process, the laboratory is committed to a customer-centric approach. This ensures a comprehensive solution that goes beyond testing, inspection, and certification, offering clients a holistic approach to products and services.
IPO's Weaknesses
-
The company heavily relies on a few customers for a significant portion of its revenues.
-
The company, some of our Promoters and our Group Company are involved in certain legal proceedings.
-
The Company owes dues to micro, small and medium enterprises.
-
The company is obligated to maintain specific licenses, approvals, registrations, consents, and permits as part of its regular business operations.
-
Negative cash flow was experienced by the company in recent fiscal periods.
-
Borrowings from commercial banks have been incurred by the company, raising concerns about repayment compliance.
-
The group companies have faced losses in previous periods.
IPO GMP Today
The Latest GMP of Qualitek Labs SME IPO GMP is Rs. 60.
Conclusion
The company operates within a highly competitive market segment and has experienced negative cash flow in the past. Despite posting substantial profits in recent years, the sustainability of these profits is uncertain. Investors might consider applying for the issue after thoroughly analyzing all relevant factors.
Finowings IPO Analysis
Hope you enjoyed the Finowings IPO Analysis. We tried our best to give every required detail about the company that you should know before applying to the IPO.
You must consult your financial advisor before making any financial decisions.
To Apply for the IPO, Click Here.
To Read the Prospectus of the Company Click Here to Download the DRHP.
Thank You for reading this blog.
Hope you loved the IPO analysis.
Please Comment Below with your feedback because Your feedback motivates us to deliver more such content.
Follow MUKUL AGRAWAL for the latest IPO news and reviews. You can connect with us on social media platforms like Twitter, Facebook, and Instagram. You can also subscribe to our YouTube Channel for the latest videos of the stock market.
Frequently Asked Questions
Qualitek Labs Limited offers testing, inspection, homologation, certification, and consultancy services across various industries, including automotive, defence, metals and metallurgy, environment and water, minerals, food and agriculture, pharma, and healthcare
Established in 2018, Qualitek Labs started its operations in Pune. In 2022, it expanded by inaugurating a second laboratory in Bhubaneshwar. The company is currently in the process of establishing two additional testing laboratories in Pune and Noida.
The IPO subscription is scheduled from January 18, 2024, to January 22, 2024. The IPO price is set at Rs. 100 per share, with a lot size of 1200 shares. The listing is expected on January 25, 2024, and the total issue size is Rs. 19.64 Crores.
As of September 30, 2023, the company reported a revenue of Rs. 1250.74 lakhs and a net profit of Rs. 200.93 lakhs. The IPO proceeds will be utilized for capital expenditure, repayment of unsecured loans to the promoter, funding working capital requirements, and general corporate purposes.
Qualitek Labs Limited boasts an experienced leadership team, a well-established brand, robust technical capabilities, and a customer-centric approach. However, it faces challenges such as reliance on a few customers, legal proceedings, dues to micro, small, and medium enterprises, and negative cash flow in recent fiscal periods.